Neurophet and VHIR Begin Joint Study on AI Imaging for Multiple Sclerosis

May 26, 2026
Neurophet has announced a collaboration with Spain’s Vall d'Hebron Institut de Recerca to advance AI algorithms for detecting multiple sclerosis lesions using MRI data. The study will use large datasets to validate Neurophet AQUA MS, which received FDA clearance in 2024.

Neurophet has announced in a press release a joint research collaboration with VHIR, the research institute of Vall d'Hebron University Hospital in Spain, to develop and validate artificial intelligence algorithms for multiple sclerosis analysis.

The study will focus on Neurophet AQUA MS, a quantitative imaging software module designed to detect multiple sclerosis lesions based on magnetic resonance imaging. VHIR will contribute de-identified brain MRI data and expert-annotated lesion labels from over 1,000 patients. Using this dataset, Neurophet will train and validate algorithms for detecting imaging biomarkers such as the Central Vein Sign and Paramagnetic Rim Lesions.

Neurophet AQUA MS is part of the company’s Neurophet AQUA brain imaging analysis platform and received FDA 510(k) clearance in October 2024. The company stated that the collaboration will help accelerate the development of clinically validated AI technology for use in regions with higher multiple sclerosis prevalence, including the United States and Europe.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/26
Brain Navi Introduces NaoTrac Surgical Robot for Precision Neurosurgery
05/26
Insilico Medicine and Human Longevity Partner on AI Foundation Model for Longevity Science
05/26
Deerborne Group to Attend ASCO 2026 and Highlight AI Platform COMPASS 360
05/26
Parkinson's Foundation Identifies 2,000 Participants for Neuron23 Trial Through PD Trial Navigator
05/26
Octagos Launches Ask Atlas for Cardiac Device Clinics

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like